ANI Pharmaceuticals
ANIP
ANIP
116 hedge funds and large institutions have $206M invested in ANI Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $241M → $206M (-$35.3M)
62% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 29
Holders
116
Holding in Top 10
–
Calls
$2.14M
Puts
$852K
Top Buyers
| 1 | +$4.38M | |
| 2 | +$2.69M | |
| 3 | +$1.57M | |
| 4 |
BGC
Birch Grove Capital
New York
|
+$1.43M |
| 5 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$1.2M |
Top Sellers
| 1 | -$2.1M | |
| 2 | -$1.94M | |
| 3 | -$1.67M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.49M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.43M |